MR spectroscopy may be useful in glioblastoma treatment assessment

07/31/2013 | HealthNewsDigest.com

Researchers at the Winship Cancer Institute of Emory University have been studying ways to assess drug treatment response in glioblastoma patients, and their efforts recently got a boost with a $4 million National Cancer Institute grant. The team has been using magnetic resonance spectroscopy to assess changes in tumor metabolism. "It lets us see something we otherwise couldn't see, something that can help us make best decisions for our patients. Glioblastoma is just an awful disease, and anything that can lighten the burden is tremendously important," said neurosurgeon Dr. Jeffrey Olson.

View Full Article in:

HealthNewsDigest.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations